Don’t add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation
Key result
Adding aspirin to anticoagulation in patients with atrial fibrillation and stable vascular disease is not recommended due to a lack of evidence for benefit and potential for harm.
Why the study?
Does adding aspirin to anticoagulation reduce stroke or other vascular events in patients with atrial fibrillation and stable vascular disease?
Population
Patients with atrial fibrillation and associated chronic stable coronary or peripheral artery disease…
Comparison
Addition of aspirin vs Anticoagulation alone (e.g., warfarin)
Design
Editorial
Authors
Discussion
Loading...
Member takes
Implication
Adding aspirin to anticoagulation in patients with atrial fibrillation and stable vascular disease lacks evidence of benefit and carries potential for harm.
Structured PICO
Does adding aspirin to anticoagulation reduce stroke or other vascular events in patients with atrial fibrillation and stable vascular disease?
P
Population
Patients with atrial fibrillation and associated chronic stable coronary or peripheral artery disease receiving anticoagulation
I
Intervention
Addition of aspirin (or other antiplatelet treatment)
C
Comparator
Anticoagulation alone (e.g., warfarin)
O
Outcome
Stroke or other vascular eventshard clinical
Adding aspirin to anticoagulation in patients with atrial fibrillation and stable vascular disease lacks evidence of benefit and carries potential for harm.
Cite This Study
Gregory Y.H. Lip (2008) conducted an editorial in Atrial fibrillation with associated chronic stable coronary or peripheral artery disease. Aspirin added to anticoagulation vs. Anticoagulation alone was evaluated. Adding aspirin to anticoagulation in patients with atrial fibrillation and stable vascular disease is not recommended due to a lack of evidence for benefit and potential for harm.